Microalbuminuria in essential hypertension

Journal of Human Hypertension

Volumn 10, Issue 10, 1996, Pages 657-661

  Mimran, A ^a   Ribstein, J ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Albuminuria; Essential hypertension; Kidney

Indexed keywords

ATENOLOL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ISRADIPINE; METOPROLOL; NITRENDIPINE;

ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; CARDIOVASCULAR RISK; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; FOLLOW UP; GLOMERULUS FILTRATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MICROALBUMINURIA; OBESITY; PREVALENCE; SMOKING;

ALBUMINURIA; ANIMALS; HUMANS; HYPERTENSION;

EID: 0030449087     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Weisstuch JM, Dworkin LD. Does essential hypertension cause end-stage renal disease? Kidney Int 1992; 41 (Suppl 36): 33-37.
2. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673-689.
3. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy: an 8-year prospective study. Kidney Int 1992; 41: 811-828.
4. Forsblom CM, Groop P, Ekstrand A, Groop LC. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 1992; 305: 1051-1053.
5. Marshall SM. Screening for microalbuminuria: which measurement? Diabetic Med 1991; 8: 706-711.
6. Hoegholm A et al. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension and normotension. Hypertension 1994; 24: 101-105.
7. Ellis D et al. Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis 1989; 13: 321-328.
8. Mimran A, Ribstein J, DuCailar G, Halimi JM. Albuminuria in normal and essential hypertension. J Diab Complic 1994; 8: 150-156.
9. Cerasola G et al. Microalbuminuria, renal dysfunction and cardiovascular complications in essential hypertension. J Hypertens 1996; 14: 915-920.
10. Gould MM et al. Microalbuminuria: associations with height and sex in non-diabetic subjects. Br Med J 1993; 306: 240-242.
11. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med 1992; 93: 525-528.
12. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94-97.
13. Summerson JH, Bell RA, Konen JC. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis 1995; 26: 577-579.
14. Weir MR. Salt intake and hypertensive renal injury in African-Americans. A therapeutic perspective. Am J Hypertens 1995; 8: 635-644.
15. Ljungman S. Microalbuminuria in essential hypertension. Am J Hypertens 1990; 3: 956-960.
16. Halimi JM, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995; 13: 1801-1802.
17. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
18. Yoshioka T et al. 'Intact nephrons' as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. J Clin Invest 1988; 82: 1614-1623.
19. Mimran A, Ribstein J. Hyperfiltration in lean essential hypertension. Karger, Basel. Contrib Nephrol 1996; 119: 98-102.
20. Mimran A, Ribstein J, DuCailar G. Is microalbuminuria a marker of early intrarenal vascular damage in essential hypertension? Hypertension 1994; 23: 878-883.
21. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 1987; 294: 1651-1654.
22. Jones SL et al. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 1989; 298: 487-490.
23. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci 1995; 88: 629-633.
24. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; 2: 530-533.
25. Samuelsson O et al. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Gotebord, Sweden. J Hypertens 1985; 3: 167-176.
26. Bigazzi R et al. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995; 9: 827-833.
27. Bianchi S et al. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7: 23-29.
28. Bianchi S et al. Insulin resistance in microalbuminuric hypertension. Hypertension 1995; 26: 789-795.
29. Weir MR, Dengel DR, Behrens MT, Goldberg AP. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995; 25: 1339-1344.
30. Pedrinelli R. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18.
31. Taddei S et al. Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients. J Hypertens 1995; 13: 1003-1008.
32. Schmieder RE et al. Predictors for hypertensive nephropathy: results of a 6-year follow-up study in essential hypertension. J Hypertens 1994; 13: 357-365.
33. Halirni JM et al. Albuminuria predicts renal functional outcome after intervention in atheromatous renovascular disease. J Hypertens 1995; 13: 1335-1342.
34. Schmieder RE et al. Impact of antihypertensive therapy with Isradipine and Metoprolol on early markers of hypertensive nephropathy. Am J Hypertens 1992; 5: 318-321.
35. Reams GP, Hamory A, Lau A, Bauer JH. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension 1988; 11: 452-456.
36. Mathiesen ER, Hommel E, Giese J, Parving H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 81-86.